- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 12 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- 4 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
PCW.3: 6 residues within 4Å:- Chain A: W.495
- Chain D: F.472, Q.473, M.474, L.475
- Ligands: POV.37
5 PLIP interactions:2 interactions with chain A, 3 interactions with chain D- Hydrophobic interactions: A:W.495, A:W.495, D:F.472, D:F.472, D:L.475
PCW.18: 6 residues within 4Å:- Chain A: F.472, Q.473, M.474, L.475
- Chain B: W.495
- Ligands: POV.8
5 PLIP interactions:2 interactions with chain B, 3 interactions with chain A- Hydrophobic interactions: B:W.495, B:W.495, A:F.472, A:F.472, A:L.475
PCW.29: 6 residues within 4Å:- Chain B: F.472, Q.473, M.474, L.475
- Chain C: W.495
- Ligands: POV.23
5 PLIP interactions:3 interactions with chain B, 2 interactions with chain C- Hydrophobic interactions: B:F.472, B:F.472, B:L.475, C:W.495, C:W.495
PCW.43: 6 residues within 4Å:- Chain C: F.472, Q.473, M.474, L.475
- Chain D: W.495
- Ligands: POV.34
6 PLIP interactions:4 interactions with chain C, 2 interactions with chain D- Hydrophobic interactions: C:F.472, C:F.472, C:F.472, C:L.475, D:W.495, D:W.495
- 28 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
POV.4: 5 residues within 4Å:- Chain A: M.435, S.448, G.449, P.453
- Ligands: POV.15
Ligand excluded by PLIPPOV.5: 12 residues within 4Å:- Chain A: C.346, C.347, L.373, Y.377, L.386, E.389, V.393, V.436, T.439, R.443, L.444, M.454
Ligand excluded by PLIPPOV.6: 3 residues within 4Å:- Chain A: V.441, I.445, A.447
Ligand excluded by PLIPPOV.7: 18 residues within 4Å:- Chain A: I.341, T.344, M.345, I.348, Y.349, W.462, V.465
- Chain B: W.495, A.498, V.499, L.502, Y.509, D.525, Y.526, P.527
- Ligands: POV.8, POV.9, Y01.25
Ligand excluded by PLIPPOV.8: 17 residues within 4Å:- Chain A: K.322, R.326, P.327, C.330, M.331, G.333, A.334, V.465, M.466, A.469, F.472, L.475
- Chain B: W.495, L.496, V.499
- Ligands: POV.7, PCW.18
Ligand excluded by PLIPPOV.9: 11 residues within 4Å:- Chain A: I.341, C.342, M.345, C.346, Y.349, K.381, I.384, R.385, V.387, V.391
- Ligands: POV.7
Ligand excluded by PLIPPOV.11: 7 residues within 4Å:- Chain A: F.553, I.557, I.564
- Chain D: F.456
- Ligands: Y01.10, Y01.42, POV.44
Ligand excluded by PLIPPOV.15: 7 residues within 4Å:- Chain A: F.456
- Chain B: F.553, I.557, I.564
- Ligands: Y01.2, POV.4, Y01.14
Ligand excluded by PLIPPOV.19: 5 residues within 4Å:- Chain B: M.435, S.448, G.449, P.453
- Ligands: POV.26
Ligand excluded by PLIPPOV.20: 11 residues within 4Å:- Chain B: C.346, L.373, Y.377, L.386, E.389, V.393, V.436, T.439, R.443, L.444, M.454
Ligand excluded by PLIPPOV.21: 3 residues within 4Å:- Chain B: V.441, I.445, A.447
Ligand excluded by PLIPPOV.22: 18 residues within 4Å:- Chain B: I.341, T.344, M.345, I.348, Y.349, W.462, V.465
- Chain C: W.495, A.498, V.499, L.502, Y.509, D.525, Y.526, P.527
- Ligands: POV.23, POV.24, Y01.39
Ligand excluded by PLIPPOV.23: 17 residues within 4Å:- Chain B: K.322, R.326, P.327, C.330, M.331, G.333, A.334, V.465, M.466, A.469, F.472, L.475
- Chain C: W.495, L.496, V.499
- Ligands: POV.22, PCW.29
Ligand excluded by PLIPPOV.24: 11 residues within 4Å:- Chain B: I.341, C.342, M.345, C.346, Y.349, K.381, I.384, R.385, V.387, V.391
- Ligands: POV.22
Ligand excluded by PLIPPOV.26: 7 residues within 4Å:- Chain B: F.456
- Chain C: F.553, I.557, I.564
- Ligands: Y01.17, POV.19, Y01.25
Ligand excluded by PLIPPOV.30: 5 residues within 4Å:- Chain C: M.435, S.448, G.449, P.453
- Ligands: POV.40
Ligand excluded by PLIPPOV.31: 12 residues within 4Å:- Chain C: C.346, L.373, Y.377, L.386, E.389, V.393, V.436, T.439, M.440, R.443, L.444, M.454
Ligand excluded by PLIPPOV.32: 3 residues within 4Å:- Chain C: V.441, I.445, A.447
Ligand excluded by PLIPPOV.33: 18 residues within 4Å:- Chain C: I.341, T.344, M.345, I.348, Y.349, W.462, V.465
- Chain D: W.495, A.498, V.499, L.502, Y.509, D.525, Y.526, P.527
- Ligands: Y01.10, POV.34, POV.35
Ligand excluded by PLIPPOV.34: 17 residues within 4Å:- Chain C: K.322, R.326, P.327, C.330, M.331, G.333, A.334, V.465, M.466, A.469, F.472, L.475
- Chain D: W.495, L.496, V.499
- Ligands: POV.33, PCW.43
Ligand excluded by PLIPPOV.35: 13 residues within 4Å:- Chain C: L.338, I.341, C.342, M.345, C.346, Y.349, K.381, I.384, R.385, V.387, G.388, V.391
- Ligands: POV.33
Ligand excluded by PLIPPOV.36: 18 residues within 4Å:- Chain A: W.495, A.498, V.499, L.502, Y.509, D.525, Y.526, P.527
- Chain D: I.341, T.344, M.345, I.348, Y.349, W.462, V.465
- Ligands: Y01.14, POV.37, POV.38
Ligand excluded by PLIPPOV.37: 17 residues within 4Å:- Chain A: W.495, L.496, V.499
- Chain D: K.322, R.326, P.327, C.330, M.331, G.333, A.334, V.465, M.466, A.469, F.472, L.475
- Ligands: PCW.3, POV.36
Ligand excluded by PLIPPOV.38: 11 residues within 4Å:- Chain D: I.341, C.342, M.345, C.346, Y.349, K.381, I.384, R.385, V.387, V.391
- Ligands: POV.36
Ligand excluded by PLIPPOV.40: 7 residues within 4Å:- Chain C: F.456
- Chain D: F.553, I.557, I.564
- Ligands: Y01.28, POV.30, Y01.39
Ligand excluded by PLIPPOV.44: 5 residues within 4Å:- Chain D: M.435, S.448, G.449, P.453
- Ligands: POV.11
Ligand excluded by PLIPPOV.45: 12 residues within 4Å:- Chain D: C.346, C.347, L.373, Y.377, L.386, E.389, V.393, V.436, T.439, R.443, L.444, M.454
Ligand excluded by PLIPPOV.46: 3 residues within 4Å:- Chain D: V.441, I.445, A.447
Ligand excluded by PLIP- 1 x CA: CALCIUM ION(Non-covalent)
- 1 x R2R: ruthenium(6+) azanide pentaamino(oxido)ruthenium (1/4/2)(Non-covalent)
R2R.13: 13 residues within 4Å:- Chain A: T.539, I.541, D.542
- Chain B: T.539, I.541, D.542
- Chain C: T.539, I.541, D.542
- Chain D: T.539, I.541, D.542
- Ligands: CA.12
20 PLIP interactions:4 interactions with chain D, 4 interactions with chain C, 6 interactions with chain B, 6 interactions with chain A- Hydrogen bonds: D:T.539, D:T.539, D:T.539, D:D.542, C:T.539, C:T.539, C:T.539, C:D.542, B:T.539, B:T.539, B:T.539, B:D.542, B:D.542, B:D.542, A:T.539, A:T.539, A:T.539, A:D.542, A:D.542, A:D.542
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Neuberger, A. et al., Structural mechanisms of TRPV6 inhibition by ruthenium red and econazole. Nat Commun (2021)
- Release Date
- 2021-11-17
- Peptides
- Transient receptor potential cation channel subfamily V member 6: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 12 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- 4 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
- 28 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- 1 x CA: CALCIUM ION(Non-covalent)
- 1 x R2R: ruthenium(6+) azanide pentaamino(oxido)ruthenium (1/4/2)(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Neuberger, A. et al., Structural mechanisms of TRPV6 inhibition by ruthenium red and econazole. Nat Commun (2021)
- Release Date
- 2021-11-17
- Peptides
- Transient receptor potential cation channel subfamily V member 6: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.